All Programs

Use the tool below to view all available Prova Series

NEW EPISODE
ADT Intensification: The Evidence You Can’t Afford to Miss
ADT Intensification: The Evidence You Can’t Afford to Miss
MinuteCE®
ADT Intensification: The Evidence You Can’t Afford to Miss
Scott T. Tagawa, MD, MS; Mary-Ellen Taplin, MD
1.00 program credit
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credit
NEW EPISODE
De Novo mHSPC: Recognizing the Patients Who Need More
De Novo mHSPC: Recognizing the Patients Who Need More
MinuteCE®
De Novo mHSPC: Recognizing the Patients Who Need More
Scott T. Tagawa, MD, MS; Mary-Ellen Taplin, MD
1.00 program credit
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credit
NEW EPISODE
Case: Implementing ADT Intensification in mHSPC
Case: Implementing ADT Intensification in mHSPC
MinuteCE®
Case: Implementing ADT Intensification in mHSPC
Scott T. Tagawa, MD, MS; Mary-Ellen Taplin, MD
1.00 program credit
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credit
IBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
IBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
CME/CE
IBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
Florence Odufalu, MD; Ugo Iroku, MD, MHS
0.50 credits
- Florence Odufalu, MD
- Ugo Iroku, MD, MHS
0.50 credits
DESTINY-Breast05 Findings Lead to New Indication for Trastuzumab Deruxtecan as Adjuvant Treatment for Residual Invasive Disease
DESTINY-Breast05 Findings Lead to New Indication for Trastuzumab Deruxtecan as Adjuvant Treatment for Residual Invasive Disease
Oncology and Hematology
DESTINY-Breast05 Findings Lead to New Indication for Trastuzumab Deruxtecan as Adjuvant Treatment for Residual Invasive Disease
Sara A. Hurvitz, MD, FACP
- Sara A. Hurvitz, MD, FACP
MinuteCE®
IBD Care Reimagined: Personalized, Proactive, and Target-Driven Management
David T. Rubin, MD; Michael Dolinger, MD, MBA
2.00 credits 3 episodes
- David T. Rubin, MD
- Michael Dolinger, MD, MBA
- Florence Odufalu, MD
- Ugo Iroku, MD, MHS
- Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
2.00 credits 3 episodes
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
CME/CE Virtual Event
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
July 08, 2026
06:00 PM - 07:30 PM ET
1.50 credits
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
MinuteCE®
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
Adam J. Luginbuhl, MD
0.50 program credits
- Adam J. Luginbuhl, MD
0.50 program credits
Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
MinuteCE®
Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
Jennifer Johnson, MD, PhD
0.50 program credits
- Jennifer Johnson, MD, PhD
0.50 program credits
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
MinuteCE®
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
Adam J. Luginbuhl, MD; Jennifer Johnson, MD, PhD
0.50 program credits
- Adam J. Luginbuhl, MD
- Jennifer Johnson, MD, PhD
0.50 program credits
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
CME/CE
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
Neeraj Agarwal, MD, FASCO; Rana McKay, MD
0.25 credits
- Neeraj Agarwal, MD, FASCO
- Rana McKay, MD
0.25 credits
IBD in Focus: A Case-Based Approach to Diagnosis and Assessment
IBD in Focus: A Case-Based Approach to Diagnosis and Assessment
CME/CE
IBD in Focus: A Case-Based Approach to Diagnosis and Assessment
David T. Rubin, MD; Michael Dolinger, MD, MBA
0.25 credits
- David T. Rubin, MD
- Michael Dolinger, MD, MBA
0.25 credits
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
CME/CE
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Enriqueta Felip, MD; Kristi Orbaugh, MSN, RNP, AOCN
0.25 credits
- Enriqueta Felip, MD
- Kristi Orbaugh, MSN, RNP, AOCN
0.25 credits
Putting It All Together: Challenges Addressed
Putting It All Together: Challenges Addressed
MinuteCE®
Putting It All Together: Challenges Addressed
David T. Rubin, MD; Ugo Iroku, MD, MHS
1.00 program credit
- David T. Rubin, MD
- Ugo Iroku, MD, MHS
1.00 program credit
Beyond Biology: Environmental and Lifestyle Influences in IBD
Beyond Biology: Environmental and Lifestyle Influences in IBD
MinuteCE®
Beyond Biology: Environmental and Lifestyle Influences in IBD
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP; Florence Odufalu, MD
1.00 program credit
- Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
- Florence Odufalu, MD
1.00 program credit
Understanding the Microbiome’s Role in IBD Management
Understanding the Microbiome’s Role in IBD Management
MinuteCE®
Understanding the Microbiome’s Role in IBD Management
Florence Odufalu, MD
1.00 program credit
- Florence Odufalu, MD
1.00 program credit

All Programs

Popular

Title